Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CALIMETRIX LLC
- Proposal award date
- 2018-04-01
- Contract end date
- 2020-03-31
- UEI
- DF57MMBTUU55
- Solicitation number
- PA18-591
- Topic code
- NIBIB
Research abstract
PROJECT SUMMARYThe overall goal of this Phase I proposal is to designdevelop and test the feasibility of advanced
quantitative magnetic resonance imagingMRIphantoms that mimic the simultaneous presence of fatiron
and fibrosisFatiron and fibrosis are three principal histological coexisting features of many important disease
statesPhantoms are highly controlled test objects that accurately reflect tissue characteristics in both normal
and pathological tissuesEmerging quantitative MRI methods introduced in the pastyears are increasingly
used for non invasive diagnosisstaging and treatment monitoring in both clinical care and clinical trialsHoweverthe lack of viable MRI phantoms that mimic the combination of fatiron and fibrosis experienced in
disease states is a major barrier to the development of new quantitative MRI biomarkersas well as effective
quality assurance in clinical environmentsSuch phantoms are also needed for quality assurancecalibration
and qualification of MRI scanners for use in multicenter drug development trialsIn this proposalwe will develop and optimize novel quantitative MRI phantoms for the validation and
quality assurance of MRI techniques to assess fatiron and fibrosis in tissueIn this collaborative project
between CalimetrixLLCand the University of Wisconsin Madisonwe will designoptimize and validate the
formulation of the individual vials comprising the phantomAimas well as the phantom housingAimand we will validate the complete phantom using established techniques as well as novel rapid MRI methods
used for multiple emerging quantitative applicationsAimSuccessful designdevelopment and validation of
advanced phantoms that accurately reflect tissue characteristics are a critical step in the development and
dissemination of quantitative imaging biomarkerswhich will have major impact by reducing costimproving
safetyand improving the early diagnosis and interventionaffecting the health of millions of Americans PUBLIC HEALTH RELEVANCE STATEMENTThe broadlong term objective of our research is to improve the health of millions of Americans who suffer
from chronic diseases such as nonalcoholic fatty liver disease or cardiomyopathyNew magnetic resonance
imaging methods are able to quantify important disease featuresproviding non invasive ways to evaluate the
presence and severity of a variety of diseasesThe development and implementation of such quantitative
imaging methods requires highly controlled and reliable test objectsorphantomsthat accurately mimic the
presence of diseasethis proposal aims to develop and test the feasibility of a novel MRI phantom
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
5 SBIR/STTR records share this UEI (2018–2025). Reported award amounts total $2,521,816. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Commerce
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards